Power morcellators are small machines used to help remove fibroids in the body. Usually used on women, power morcellators offer a non-invasive approach to removing benign tumors in the body through the use of small rotating blades that cut and remove the tissues from small incisions. It is a common surgical procedure used for hysterectomies and myomectomies, and is a great option because it offers little down time and faster recovery. However, reports of cancers developing in patients who have undergone surgery using the power morcellator have recently escalated and the resulting number of lawsuits has prompted the Food and Drug Administration (FDA) to issue a safety alert for those who are considering the use of power morcellators in hysterectomies and myomectomies.
A very dangerous form of uterine cancer, metastatic leiomyosarcanoma, can develop from using the power morcellators. The rotating blades of the morcellators do remove the fibroid tumors in the uterus, but they can also spread the tissue fragments that could have been cancerous in nature. These undiscovered cancerous tissue fragments then latch on surrounding tissues or organs, causing cancerous growths that are potentially life-threatening.
Known as being the fourth most common form of cancer in women, uterine cancer generally occurs in the lining of the uterus and is caused by the rapid and abnormal reproduction of cancer cells that result in the growth of tumors. Because it is very difficult to determine whether the tumors are benign fibroids or are actually cancerous, when these tumors are removed by the power morcellators and spread to other areas inside the body, this result to metastatic leiomyosarcanoma. The cancer is often diagnosed as either stage III or stage IV, with a five-year survival rate of 4-16 percent compared to 50 percent of those who have non-metastatic leiomyosarcanoma. There are a lot of websites that provide more information to help you better understand metastatic leiomyosarcoma, all you have to go is go online to view more.
Although it is recommended and advised to do a pre-screening for uterine cancer before any fibroid or hysterectomy surgery, it can be difficult to determine metastatic leiomyosarcoma because they resemble benign fibroids and can only be diagnosed after being extracted and gone through post-surgical pathology. The manufacturer and even the medical professionals can be held liable for the spread of cancer in the patient’s body due to power morcellators because the risks was already known in the medical world, and patient’s have the right to know that the medical device have the potential to spread the undetected cancer cells to other parts of the body.